Brief: Egetis Therapeutics FY Adjusted EPS SEK -1.3

Egetis Therapeutics AB (publ)

22/02/2024 06:00

Feb 22 (Reuters) - Egetis Therapeutics FY revenue SEK 57.6 million vs. IBES
estimate SEK 36.2 million.
* FY net income SEK -326.9 million